Researchers Investigate High Rates of MDR- and Rifampicin-Resistant TB Among Re-Treatment Cases
Infection Control Today,
Globally, 3.9 percent of new and 21 percent of re-treatment tuberculosis (TB) cases are multidrug-resistant or rifampicin-resista…